Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy AzurRx BioPharma stock

Learn how to easily invest in AzurRx BioPharma stock.

AzurRx BioPharma is a biotechnology business based in the US. AzurRx BioPharma shares (AZRX) are listed on the NASDAQ and all prices are listed in US Dollars. AzurRx BioPharma employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy AzurRx BioPharma stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – AZRX. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Promoted

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

AzurRx BioPharma stock price (NASDAQ: AZRX)

Use our graph to track the performance of AZRX stocks over time.

AzurRx BioPharma shares at a glance

Information last updated 2022-01-16.
52-week range$0.00 - $0.00
50-day moving average $4.94
200-day moving average $7.50
Wall St. target price$16.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-15.49

Buy AzurRx BioPharma stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy AzurRx BioPharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AzurRx BioPharma price performance over time

Historical closes compared with the close of $N/A from 2021-12-08

1 week (2023-01-16) N/A
1 month (2022-12-23) N/A
3 months (2022-10-23) N/A
6 months (2022-07-23) N/A
1 year (2022-01-23) N/A
2 years (2021-01-27) -100.00%
3 years (2020-01-27) -100.00%
5 years (2018-01-26) -100.00%

AzurRx BioPharma financials

Gross profit TTM $0
Return on assets TTM -233.79%
Return on equity TTM -1271.87%
Profit margin 0%
Book value $0.85
Market capitalisation $34.4 million

TTM: trailing 12 months

AzurRx BioPharma share dividends

We're not expecting AzurRx BioPharma to pay a dividend over the next 12 months.

Have AzurRx BioPharma's shares ever split?

AzurRx BioPharma's shares were split on a 1:10 basis on 12 September 2021. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your AzurRx BioPharma shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for AzurRx BioPharma shares which in turn could have impacted AzurRx BioPharma's share price.

AzurRx BioPharma share price volatility

Over the last 12 months, AzurRx BioPharma's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

AZRX.US volatility(beta: 1.51)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AzurRx BioPharma's is 1.5109. This would suggest that AzurRx BioPharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

AzurRx BioPharma overview

AzurRx BioPharma, Inc. , a clinical stage biopharmaceutical company, focuses on the development of recombinant proteins for the treatment of gastrointestinal diseases. Its therapeutic products administer patients as oral non-systemic biologics. The company's lead therapeutic is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency. It is also developing two clinical programs using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor, including FW-420, for grade 1 Immune Checkpoint Inhibitor-associated colitis and diarrhea in oncology patients; and FW-1022, for COVID-19 gastrointestinal infections. AzurRx BioPharma, Inc. has a license agreement with First Wave Bio, Inc.

Frequently asked questions

What percentage of AzurRx BioPharma is owned by insiders or institutions?
Currently 0.767% of AzurRx BioPharma shares are held by insiders and 5.821% by institutions.
How many people work for AzurRx BioPharma?
Latest data suggests 12 work at AzurRx BioPharma.
When does the fiscal year end for AzurRx BioPharma?
AzurRx BioPharma's fiscal year ends in December.
Where is AzurRx BioPharma based?
AzurRx BioPharma's address is: 777 Yamato Road, Boca Raton, FL, United States, 33431
What is AzurRx BioPharma's ISIN number?
AzurRx BioPharma's international securities identification number is: US33749P1012
What is AzurRx BioPharma's CUSIP number?
AzurRx BioPharma's Committee on Uniform Securities Identification Procedures number is: 05502L105

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site